Sources: AP
The U.S. FDA grants approval for the Pfizer–BioNTech COVID-19 vaccine for people aged between 12 and 17. 2022-07-8
Mexican president Andrés Manuel López Obrador tests positive for COVID-19 for the second time. 2022-01-10
Mexican health regulator COFEPRIS grants emergency use authorization for Merck & Co.'s anti-COVID-19 drug Molnupiravir for the treatment of severe disease. 2022-01-7
The Therapeutic Goods Administration provisionally approves the usage of the Pfizer–BioNTech COVID-19 vaccine for children between the ages of 5 and 11 years. Vaccination rollout for this age group will begin on January 10, once ATAGI gives its recommendation. 2021-12-5
Bahrain's National Health Regulatory Authority approves the emergency use of the Pfizer–BioNTech COVID-19 vaccine for children between the ages of 5 and 11 years old. 2021-11-2
The Food and Drug Administration officially authorizes the usage of a third dosage of the Pfizer–BioNTech COVID-19 vaccine as a booster shot for individuals still considered vulnerable to COVID-19. Among those eligible are health care workers and senior citizens who have been fully inoculated with the vaccine for at least six months. 2021-09-22
Mexico reports 16,244 new cases of COVID-19 in the past 24 hours, the highest daily total in the country since January. 2021-07-22
The government signs an agreement with Pfizer to purchase 40 million doses of the Pfizer–BioNTech vaccine, the Philippines' largest supply agreement for a COVID-19 vaccine. 2021-05-17
Rwanda begins a vaccination campaign against COVID-19 using 392,000 doses of the Oxford–AstraZeneca and Pfizer–BioNTech vaccines. 2021-03-5
Mexico reports their first case of a new variant of SARS-CoV-2 from the United Kingdom. 2021-01-10